Financial Performance - Vuzix's 2Q2022 revenue reached $3.01 million, reflecting a 20% sequential increase and a 3% year-over-year increase[14, 27] - Gross profit for 2Q2022 was $0.43 million, with a gross margin of 14.2%, representing a 27% decrease in gross profit and a 29% decrease in gross margin compared to 1Q2021[27] - Operating loss for 2Q2022 was $(10.00) million, a 9% decrease compared to $(9.21) million in 1Q2021[27] - Loss per share (EPS) for 2Q2022 was $(0.16), a 7% decrease compared to $(0.15) in 1Q2021[27] - As of June 30, 2022, Vuzix held $100.6 million in cash, with current assets of $116.9 million and working capital of $109.1 million[29] Business Updates - Smart glasses customer engagements are encouraging, particularly in warehousing and logistics, with a Fortune 100 customer scheduling a multi-year rollout[14, 15] - Vuzix expects smart glasses revenue to grow in the second half of 2022 compared to the second half of 2021[15] - The company expanded its international sales channel by adding Westbase.io and bolstered local sales and support teams in Europe, with a German sales office planned to open in 3Q2022[14] - Vuzix is expanding its waveguide manufacturing quality and capacity and is the only US-based supplier of waveguides for defense customers[18] Product Development - Vuzix anticipates releasing three new products over the next several months, including a Blade follow-on product and the M400-C, with initial production units already shipped[25] - The introduction of Shield, Vuzix's next-generation smart glasses, is on track for introduction well before the end of 2H2022[25]

[Part I – Financial Information](index=4&type=section&id=Part%20I%20%E2%80%93%20Financial%20Information) [Consolidated Financial Statements](index=4&type=section&id=Item%201.%20Consolidated%20Financial%20Statements) This section presents Vuzix Corporation's unaudited consolidated financial statements for Q2 and H1 2022, covering balance sheets, operations, equity, cash flows, and detailed notes [Consolidated Balance Sheets](index=4&type=section&id=Consolidated%20Balance%20Sheets) The balance sheet as of June 30, 2022, shows decreased total assets and increased total liabilities due to new licensing fee commitments Consolidated Balance Sheet Highlights (as of June 30, 2022 vs. Dec 31, 2021) | Balance Sheet Item | June 30, 2022 ($ millions) | December 31, 2021 ($ millions) | | :--- | :--- | :--- | | Cash and Cash Equivalents | $100.6 | $120.2 | | Total Current Assets | $116.9 | $137.2 | | Total Assets | $145.9 | $148.5 | | Total Current Liabilities | $7.8 | $4.2 | | Total Liabilities | $14.4 | $4.7 | | Total Stockholders' Equity | $131.5 | $143.7 | [Consolidated Statements of Operations](index=7&type=section&id=Consolidated%20Statements%20of%20Operations) Q2 2022 saw a slight sales increase but widened net loss, while H1 2022 experienced decreased sales and a larger net loss Statement of Operations Summary (Three Months Ended June 30) | Metric | 2022 ($ millions) | 2021 (Restated) ($ millions) | | :--- | :--- | :--- | | Total Sales | $3.0 | $2.9 | | Gross Profit | $0.4 | $0.6 | | Loss From Operations | ($10.0) | ($9.2) | | Net Loss | ($10.0) | ($9.2) | | Basic and Diluted Loss per Share ($) | ($0.16) | ($0.15) | Statement of Operations Summary (Six Months Ended June 30) | Metric | 2022 ($ millions) | 2021 (Restated) ($ millions) | | :--- | :--- | :--- | | Total Sales | $5.5 | $6.8 | | Gross Profit | $1.1 | $1.7 | | Loss From Operations | ($20.4) | ($18.3) | | Net Loss | ($20.5) | ($18.4) | | Basic and Diluted Loss per Share ($) | ($0.32) | ($0.31) | [Consolidated Statements of Cash Flows](index=8&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) H1 2022 saw significant cash usage in operating and investing activities, contrasting with substantial cash provided by financing in H1 2021 Cash Flow Summary (Six Months Ended June 30) | Cash Flow Activity | 2022 ($ millions) | 2021 (Restated) ($ millions) | | :--- | :--- | :--- | | Net Cash Used in Operating Activities | ($11.0) | ($13.1) | | Net Cash Used in Investing Activities | ($8.4) | ($1.2) | | Net Cash (Used in) Provided from Financing Activities | ($0.2) | $115.9 | | Net (Decrease) Increase in Cash | ($19.6) | $101.5 | [Notes to the Unaudited Consolidated Financial Statements](index=9&type=section&id=Notes%20to%20the%20Unaudited%20Consolidated%20Financial%20Statements) These notes detail key accounting policies, significant customer concentration, a major technology license agreement, and stock-based compensation expenses - In Q2 2022, one customer accounted for **45%** of total product revenue, and another single customer accounted for **100%** of engineering services revenue, indicating **significant customer concentration**[20](index=20&type=chunk) - On May 12, 2022, the company signed agreements with Atomistic SAS for an exclusive mLED technology license, recording a **$15 million** intangible asset and a corresponding liability, to be amortized over **ten years**[38](index=38&type=chunk)[39](index=39&type=chunk) - The company recorded non-cash stock-based compensation expense of **$2.7 million** in Q2 2022 and **$5.6 million** in H1 2022 related to its Long-Term Incentive Plan (LTIP)[53](index=53&type=chunk) - On March 2, 2022, the Board approved a share repurchase program of up to **$25 million**, with **36,685 shares** repurchased for **$251,057** during the first six months of 2022[47](index=47&type=chunk)[118](index=118&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=18&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses financial performance for Q2 and H1 2022, highlighting revenue trends, declining gross margins, increased operating expenses, and liquidity [Results of Operations - Three Months Ended June 30, 2022 vs 2021](index=22&type=section&id=Results%20of%20Operations%20-%20Three%20Months%20Ended%20June%2030%2C%202022%20vs%202021) Q2 2022 saw a 3% sales increase but a 27% gross profit decline and 7% rise in operating expenses, resulting in an 8% higher net loss Q2 2022 vs Q2 2021 Performance | Metric | Q2 2022 ($ millions) | Q2 2021 (Restated) ($ millions) | % Change | | :--- | :--- | :--- | :--- | | Total Sales | $3.0 | $2.9 | 3% | | Gross Profit | $0.4 | $0.6 | (27)% | | Gross Margin | 14% | 20% | - | | Loss from Operations | ($10.0) | ($9.2) | 9% | | Net Loss | ($10.0) | ($9.2) | 8% | - The decrease in gross profit margin for product sales (from **18%** to **13%**) was primarily driven by **higher sales discounts** on large volume sales, **negative foreign exchange impacts**, and **higher overhead allocations**[76](index=76&type=chunk)[77](index=77&type=chunk) - R&D expenses increased by **10%** due to **external development costs** for the next-generation **'Shield' Smart Glasses** and **higher salary expenses**[81](index=81&type=chunk) - Selling and Marketing expenses grew **37%** due to **increased salary, travel, sales commissions, and trade show expenses**[83](index=83&type=chunk) [Results of Operations - Six Months Ended June 30, 2022 vs 2021](index=28&type=section&id=Results%20of%20Operations%20-%20Six%20Months%20Ended%20June%2030%2C%202022%20vs%202021) H1 2022 saw a 19% sales decrease, 36% gross profit drop, and 8% rise in operating expenses, leading to a 12% wider net loss H1 2022 vs H1 2021 Performance | Metric | H1 2022 ($ millions) | H1 2021 (Restated) ($ millions) | % Change | | :--- | :--- | :--- | :--- | | Total Sales | $5.5 | $6.8 | (19)% | | Gross Profit | $1.1 | $1.7 | (36)% | | Gross Margin | 19% | 24% | - | | Loss from Operations | ($20.4) | ($18.3) | 12% | | Net Loss | ($20.5) | ($18.4) | 12% | - Sales of Smart Glasses products decreased by **21%** or **$1.4 million** in the first six months of 2022 compared to the same period in 2021[92](index=92&type=chunk) - R&D expenses increased by **24%** (**$1.2 million**), largely due to a **$608k** increase in external development for the **'Shield' Smart Glasses** and a **$506k** increase in salary expenses[99](index=99&type=chunk) - Selling and Marketing expenses rose by **48%** (**$1.3 million**), driven by **higher salary, advertising, travel, and trade show costs**[101](index=101&type=chunk) [Liquidity and Capital Resources](index=33&type=section&id=Liquidity%20and%20Capital%20Resources) Vuzix maintains strong liquidity with $100.6 million cash, but faces significant future contractual commitments totaling $21.5 million - The company's cash and cash equivalents decreased by **$19.6 million** during the first six months of 2022, ending the period at **$100.6 million**[109](index=109&type=chunk) - Cash used in investing activities in H1 2022 was **$8.4 million**, which included **$4.5 million** for technology license commitments and **$3.5 million** for manufacturing equipment and tooling[112](index=112&type=chunk) - The company has outstanding contractual commitments of **$10.5 million** for licensing fees and approximately **$11.0 million** for a backplane chip design, both related to the Atomistic agreements[116](index=116&type=chunk) [Quantitative and Qualitative Disclosures About Market Risk](index=38&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company's primary market risks are interest rate changes and foreign currency fluctuations, with no current hedging activities - The company is exposed to market risk from changes in **interest rates** on its cash investments and **foreign currency exchange rates** related to business in Japan and Europe[127](index=127&type=chunk) - Vuzix **does not currently use hedging instruments** to mitigate its foreign currency exchange rate risk[127](index=127&type=chunk) [Controls and Procedures](index=38&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded disclosure controls were ineffective due to a material weakness in LTIP stock option valuation, with remediation ongoing - Management, including the CEO and CFO, concluded that disclosure controls and procedures were **not effective** as of the end of the quarter[128](index=128&type=chunk) - The ineffectiveness is due to a **material weakness** related to the methodology used to calculate the **fair market value of LTIP stock options** issued in March 2021[129](index=129&type=chunk) - **Remediation controls** have been designed and implemented, but not enough time has passed to fully test them, with **full remediation** expected in 2022[130](index=130&type=chunk) [Part II – Other Information](index=40&type=section&id=Part%20II%20%E2%80%93%20Other%20Information) [Legal Proceedings](index=40&type=section&id=Item%201.%20Legal%20Proceedings) The company is not currently involved in any material legal proceedings or litigation - As of the filing date, the company is **not involved in any actual or pending legal proceedings or litigation**[132](index=132&type=chunk) [Risk Factors](index=40&type=section&id=Item%201A.%20Risk%20Factors) The company faces ongoing risks from COVID-19 and geopolitical actions, impacting supply chains and requiring earlier purchase commitments - The implications of **COVID-19** and **geopolitical actions** on future operations remain uncertain, with potential for **adverse effects on revenue and manufacturing output**[134](index=134&type=chunk) - The company is experiencing **longer component lead times**, which **increases supply chain risk** and the **need to carry more inventory**[134](index=134&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=40&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company reported no unregistered sales of equity securities or purchases of equity securities during the period - There were **no unregistered sales of equity securities or purchases of equity securities** by the company during the reporting period[135](index=135&type=chunk) [Exhibits](index=41&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including CEO/CFO certifications and Inline XBRL financial data - The exhibits filed with this report include **certifications from the CEO and CFO** pursuant to **Sections 302 and 906 of the Sarbanes-Oxley Act of 2002**, as well as **Inline XBRL documents**[136](index=136&type=chunk)

Vuzix Corp, Inc. (NASDAQ:VUZI) Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants Ed McGregor - Director, IR Paul Travers - Founder, Chairman, CEO & President Grant Russell - CFO, EVP, Treasurer & Director Conference Call Participants Tyler Burmeister - Craig-Hallum Matthew VanVliet - BTIG Jack Aarde - Maxim Group James McIlree - Dawson James Securities Operator Greetings, and welcome to the Vuzix First Quarter ending March 31, 2022 Financial Results and Business Update Conference ...

[Part I – Financial Information](index=4&type=section&id=Part%20I%20%E2%80%93%20Financial%20Information) This part details the company's unaudited financial performance, condition, and related disclosures for the period [Item 1. Consolidated Financial Statements (Unaudited)](index=4&type=section&id=Item%201.%20Consolidated%20Financial%20Statements%20%28Unaudited%29) This section presents the company's unaudited consolidated financial statements, showing a decrease in assets and a widened net loss for the first quarter of 2022, with prior-year restatements Consolidated Balance Sheet Summary | Balance Sheet Data | Amount ($) as of March 31, 2022 | Amount ($) as of December 31, 2021 | | :--- | :--- | :--- | | Cash and Cash Equivalents | $113,329,734 | $120,203,873 | | Total Current Assets | $129,497,433 | $137,150,154 | | Total Assets | $140,350,176 | $148,467,057 | | Total Current Liabilities | $2,940,281 | $4,156,255 | | Total Liabilities | $3,394,346 | $4,739,131 | | Total Stockholders' Equity | $136,955,830 | $143,727,926 | Consolidated Statement of Operations Summary (Three Months Ended March 31) | Income Statement Data | Amount ($) for 2022 | Amount ($) for 2021 (as Restated) | | :--- | :--- | :--- | | Total Sales | $2,503,051 | $3,915,389 | | Gross Profit | $639,354 | $1,079,591 | | Loss From Operations | $(10,413,892) | $(9,085,965) | | Net Loss | $(10,506,001) | $(9,151,370) | | Basic and Diluted Loss per Common Share | $(0.16) | $(0.17) | Consolidated Statement of Cash Flows Summary (Three Months Ended March 31) | Cash Flow Data | Amount ($) for 2022 | Amount ($) for 2021 (as Restated) | | :--- | :--- | :--- | | Net Cash Flows Used in Operating Activities | $(6,435,079) | $(5,921,629) | | Net Cash Flows Used in Investing Activities | $(217,227) | $(650,655) | | Net Cash Flows (Used in) Provided from Financing Activities | $(221,833) | $103,224,872 | | Net (Decrease) Increase in Cash and Cash Equivalents | $(6,874,139) | $96,652,588 | - The company restated its Q1 2021 financial results, which increased the previously reported **Net Loss by $2.5 million** and **Loss per Share by $0.05**, primarily due to adjustments in non-cash stock-based compensation expense[16](index=16&type=chunk)[17](index=17&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations](index=17&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) This section analyzes the company's financial performance, highlighting a significant sales decline and widened net loss in Q1 2022, while maintaining a strong liquidity position - The company is engaged in the design, manufacture, and sale of wearable computing devices like Smart Glasses and AR glasses, focusing on enterprise, industrial, commercial, medical, and security markets[61](index=61&type=chunk)[63](index=63&type=chunk) - On March 2, 2022, the Board of Directors approved a share buyback program to repurchase up to **$25 million of common stock** over one year, with **36,685 shares repurchased** at an average price of **$6.84** during Q1 2022[89](index=89&type=chunk) [Results of Operations](index=22&type=section&id=2.1%20Results%20of%20Operations) This section details the company's Q1 2022 operational results, showing a significant decline in sales and gross profit, alongside increased R&D and marketing expenses Sales Breakdown (Three Months Ended March 31) | Sales Component | Amount ($) for 2022 | Amount ($) for 2021 | % Change | | :--- | :--- | :--- | :--- | | Sales of Smart Glasses | $2,379,398 | $3,772,481 | (37)% | | Sales of Engineering Services | $0 | $110,219 | (100)% | | **Total Sales** | **$2,503,051** | **$3,915,389** | **(36)%** | - Gross profit margin for products remained stable at **26%** for both Q1 2022 and Q1 2021[70](index=70&type=chunk) - R&D expenses increased by **41% ($0.9 million)** year-over-year, largely due to a **$0.4 million** increase in external development expenses for the Next Generation Smart Glasses (Shield)[74](index=74&type=chunk) - Selling and marketing expenses rose **55% ($0.7 million)** year-over-year, driven by increased salary expenses and a **$0.3 million** increase in trade show expenses as COVID-19 lockdowns eased[76](index=76&type=chunk) - General and administrative expenses decreased **10% ($0.6 million)** year-over-year, mainly due to a **$0.6 million** decrease in non-cash stock-based compensation related to the LTIP, which had significant vesting in Q1 2021[78](index=78&type=chunk) [Liquidity and Capital Resources](index=27&type=section&id=2.2%20Liquidity%20and%20Capital%20Resources) This section assesses the company's financial position, highlighting strong liquidity with substantial cash reserves and no debt, supported by equity financing and a new share buyback program Key Liquidity Metrics | Metric | Amount ($) as of March 31, 2022 | Amount ($) as of December 31, 2021 | | :--- | :--- | :--- | | Cash and Cash Equivalents | $113,329,734 | $120,203,873 | | Working Capital | $126,557,114 | $132,993,899 | - Net cash used in operating activities was **$6.4 million** in Q1 2022, compared to **$5.9 million** in Q1 2021[84](index=84&type=chunk) - The company has **no current or long-term debt obligations** outstanding as of March 31, 2022[87](index=87&type=chunk) - The company's operations are primarily financed through the net proceeds from the sale of its equity securities[90](index=90&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=31&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) This section outlines the company's exposure to market risks, primarily from interest rate fluctuations on cash investments and foreign currency exchange rates, without current hedging strategies - The company invests excess cash in high-quality short-term corporate debt, exposing it to minor interest rate risk[97](index=97&type=chunk) - Foreign currency exchange rate risk exists due to non-U.S. dollar denominated cash flows from operations in Japan and Europe, which the company does not currently hedge[97](index=97&type=chunk) [Item 4. Controls and Procedures](index=31&type=section&id=Item%204.%20Controls%20and%20Procedures) This section reports that disclosure controls and procedures were ineffective due to a material weakness in internal control over financial reporting related to LTIP stock option valuation, with remediation efforts underway - The CEO and CFO concluded that disclosure controls and procedures were **not effective** due to a material weakness in internal control over financial reporting[99](index=99&type=chunk) - The material weakness relates to the methodology used to calculate the fair market value of Long-Term Incentive Plan (LTIP) stock options issued in March 2021[100](index=100&type=chunk) - Remediation efforts are underway, including enhanced management reviews and processes for engaging technical accounting experts, with full remediation expected in 2022[101](index=101&type=chunk) [Part II – Other Information](index=33&type=section&id=Part%20II%20%E2%80%93%20Other%20Information) This part provides additional disclosures including legal matters, updated risk factors, equity transactions, and other relevant information [Item 1. Legal Proceedings](index=33&type=section&id=Item%201.%20Legal%20Proceedings) The company reports that it is not currently involved in any actual or pending legal proceedings or litigation - As of the report date, the company is **not involved in any legal proceedings**[103](index=103&type=chunk) [Item 1A. Risk Factors](index=33&type=section&id=Item%201A.%20Risk%20Factors) This section confirms no material changes to previously disclosed risk factors, while highlighting ongoing supply chain challenges due to global events - No material changes have occurred from the risk factors previously disclosed in the 2021 Annual Report on Form 10-K[104](index=104&type=chunk) - The company notes that COVID-19 and geo-political actions are causing shortages of certain chips and longer component lead times, increasing supply chain risk and the need for higher inventory levels[105](index=105&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=35&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section reports no unregistered equity sales and details the company's share buyback program, including shares repurchased and remaining authorization Purchase of Equity Securities (March 2022) | Period | Total Shares Purchased | Average Price Paid Per Share ($) | Maximum Dollar Value Remaining for Purchase ($) | | :--- | :--- | :--- | :--- | | March 1 - 31, 2022 | 36,685 | $6.84 | $24,748,906 | - The Board of Directors approved a repurchase program for up to **$25 million** of common stock, effective for one year starting March 2, 2022[106](index=106&type=chunk) [Item 3. Defaults Upon Senior Securities](index=35&type=section&id=Item%203.%20Defaults%20Upon%20Senior%20Securities) None - The company reports **no defaults upon senior securities**[107](index=107&type=chunk) [Item 4. Mine Safety Disclosure](index=35&type=section&id=Item%204.%20Mine%20Safety%20Disclosure) Not Applicable - This section is **not applicable** to the company[107](index=107&type=chunk) [Item 5. Other Information](index=35&type=section&id=Item%205.%20Other%20Information) None - The company reports **no other information**[107](index=107&type=chunk) [Item 6. Exhibits](index=36&type=section&id=Item%206.%20Exhibits) This section lists all exhibits accompanying the filing, including required CEO and CFO certifications and Inline XBRL documents - The report includes required certifications from the CEO and CFO, as well as Inline XBRL data files as exhibits[108](index=108&type=chunk)

Company Overview - Vuzix Corporation was founded in 1997 and had its IPO in 2009[7] - The company's market capitalization is $550 million as of December 31, 2021[7] - Vuzix's cash position was $129 million as of September 30, 2021[7] - CEO and CFO together own approximately 7% of the company, while institutional ownership is around 37%[7] Market and Products - The smart glasses market is expected to grow significantly in the future[9] - Vuzix introduced Vuzix Shield™ at CES 2022, featuring microLED-powered binocular smart glasses[21] - Healthcare and telemedicine are among Vuzix's fastest-growing verticals[38] Growth and Strategy - The enterprise market (including warehousing and remote support) and healthcare are expected to drive significant industry demand growth[55] - Vuzix is employing a 3-prong approach: investing in the core smart glasses business, pursuing SaaS solution opportunities, and advancing core technologies[64] - The company is evaluating the acquisition of a disruptive nano electro optical technology[72] Financial Performance - Vuzix's smart glasses revenue continues to grow[56] - The company projects a 51% increase in quarterly revenue[57]

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number: 001-35955 Vuzix Corporation ( Exact name of registrant as specified in its charter ) Delaware 04-3392453 (State of incorporation) (I.R.S. employer identification no.) ...

Vuzix Corporation (NASDAQ:VUZI) Q4 2021 Earnings Conference Call March 1, 2022 4:30 PM ET Company Participants Ed McGregor - Director of Investor Relations Paul Travers - Chief Executive Officer Grant Russell - Chief Financial Officer Pete Jameson - Chief Operating Officer Conference Call Participants Matt VanVliet - BTIG Christian Schwab - Craig-Hallum Jim Mcilree - Dawson James Operator Greetings, and welcome to the Vuzix Fourth Quarter and Full-Year Ending December 31 2021, Financial Results and Business ...

Par HOOD 3Q2021 EARNINGS PRESENTATION NOVEMBER 8, 2021 (R) 1 Cautionary Note Regarding Forward Looking Statements Certain statements included in this presentation may be considered forward-looking. All statements in this presentation that are not historical facts are forward-looking statements. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements, and theref ...

Vuzix Corporation (NASDAQ:VUZI) Q3 2021 Earnings Conference Call November 9, 2021 4:30 PM ET Company Participants Paul Travers – CEO Ed McGregor – Director of Investor Relations Grant Russell – CFO Conference Call Participants Tyler Burmeister – Craig Hallum Jack Vander Aarde – Maxim Group Rachel Freeman – BTIG Operator Greetings and welcome to the Vuzix Third Quarter ending September 30th, 2021 Financial Results and Business Update conference call. At this time, all participants are in a listen-only mode. ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-35955 VUZIX CORPORATION (Exact name of registrant as specified in its charter) Delaware 04-3392453 State or other jurisdiction of incorporation or orga ...